0000899243-20-014559.txt : 20200529 0000899243-20-014559.hdr.sgml : 20200529 20200529163205 ACCESSION NUMBER: 0000899243-20-014559 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200527 FILED AS OF DATE: 20200529 DATE AS OF CHANGE: 20200529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arix Bioscience Holdings Ltd CENTRAL INDEX KEY: 0001756884 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38800 FILM NUMBER: 20928451 BUSINESS ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J6EQ BUSINESS PHONE: 44(0)20 7290 1050 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J6EQ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arix Bioscience plc CENTRAL INDEX KEY: 0001700449 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38800 FILM NUMBER: 20928452 BUSINESS ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J 6EQ BUSINESS PHONE: 44(0)20 7290 1050 MAIL ADDRESS: STREET 1: 20 BERKELEY SQUARE CITY: LONDON STATE: X0 ZIP: W1J 6EQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc. CENTRAL INDEX KEY: 0001708493 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473458693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-443-7400 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-27 0 0001708493 Harpoon Therapeutics, Inc. HARP 0001700449 Arix Bioscience plc 20 BERKELEY SQUARE MAYFAIR, LONDON X0 W1J 6EQ UNITED KINGDOM 0 0 1 0 0001756884 Arix Bioscience Holdings Ltd 20 BERKELEY SQUARE MAYFAIR, LONDON X0 W1J 6EQ UNITED KINGDOM 0 0 1 0 Common stock 2020-05-27 4 S 0 12064 22.3926 D 2560295 I See Footnote Common stock 2020-05-28 4 S 0 366591 21.3342 D 2193704 I See Footnote Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $22.00 to $24.00 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission (the "SEC"), the Issuer, or a security holder of the Issuer. These shares are owned directly by Arix Bioscience Holdings Limited, which is a wholly owned subsidiary of Arix Bioscience Plc. Arix Bioscience Plc is an indirect beneficial owner of the reported securities and disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $21.25 to $22.00 per share, inclusive. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer. Arix Bioscience Plc, by: /s/ Marcus Karia, Authorized Officer 2020-05-29 Arix Bioscience Holdings Limited, by: /s/ Marcus Karia, Authorized Officer 2020-05-29